Golden State Equity Partners’s Colgate-Palmolive CL Stock Holding History

Golden State Equity Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,262	Closed	-$193K	–	582
2026 Q1	$193K	Sell	2,262 -1,318	-37%	-$117K	0.01%	637
2025 Q4	$283K	Buy	3,580 +317	+10%	+$24.9K	0.05%	408
2025 Q3	$261K	Buy	3,263 +436	+15%	+$37.2K	0.04%	377
2025 Q2	$257K	Sell	2,827 -9,340	-77%	-$853K	0.05%	366
2025 Q1	$1.14M	Buy	12,167 +4,676	+62%	+$419K	0.23%	115
2024 Q4	$681K	Sell	7,491 -3,604	-32%	-$344K	0.13%	183
2024 Q3	$1.15M	Buy	11,095 +8,462	+321%	+$862K	0.18%	124
2024 Q2	$255K	Buy	+2,633	New	+$243K	0.05%	344
2023 Q4	$200K	Sell	2,514 -361	-13%	-$27.1K	0.05%	344
2023 Q3	$204K	Buy	2,875 +11	+0.4%	+$822	0.06%	310
2023 Q2	$221K	Sell	2,864 -64	-2%	-$4.95K	0.06%	330
2023 Q1	$220K	Buy	+2,928	New	+$218K	0.12%	189

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Golden State Equity Partners's CL Position: Q2 2026 in Review

Golden State Equity Partners sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 2,262 shares — an estimated $193K sold.

Golden State Equity Partners first reported a position in CL in Q1 2023 and held it in 12 quarters. The position peaked at $1.15M in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Golden State Equity Partners reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 2,262 Colgate-Palmolive shares in Q2 2026, an estimated $193K.
Golden State Equity Partners first reported a position in Colgate-Palmolive in Q1 2023 and held it in 12 quarters.
Golden State Equity Partners's Colgate-Palmolive position peaked at $1.15M in Q3 2024.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.